Prof. Dr. med. Arndt Hartmann

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

Gpr126 (Adgrg6) is expressed in cell types known to be exposed to mechanical stimuli (2019) Musa G, Cazorla-Vázquez S, van Amerongen MJ, Stemmler M, Eckstein M, Hartmann A, Braun T, et al. Journal article Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer (2019) Fasching P, Gaß P, Häberle L, Volz B, Hein A, Hack C, Lux MP, et al. Journal article Pathology and molecular pathology of renal cell cancer Pathologie und Molekularpathologie des Nierenzellkarzinoms (2019) Erlmeier F, Agaimy A, Hartmann A, Stöhr CG Journal article, Review article Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO-04 randomized phase 3 rectal cancer trial (2019) Diefenhardt M, Hofheinz RD, Martin D, Beißbarth T, Arnold D, Hartmann A, von der Grün J, et al. Journal article Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab (2019) Eckstein M, Erben P, Kriegmair MC, Worst TS, Weiss CA, Wirtz RM, Wach S, et al. Journal article FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer (2019) Breyer J, Wirtz RM, Erben P, Rinaldetti S, Worst TS, Stoehr R, Eckstein M, et al. Journal article BRAF mutation testing in melanoma: results from a German observational multicenter study (2019) Hartmann A, Schirmacher P, Sterlacci W, Koch W, Liesenfeld DB, Schif B, Garbe C Journal article Non-Clear Cell Renal Cell Carcinoma - Pathology and Treatment Options (2019) Ahrens M, Scheich S, Hartmann A, Bergmann L Journal article, Review article Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis (2019) Fasching P, Hartkopf AD, Gaß P, Häberle L, Akpolat-Basci L, Hein A, Volz B, et al. Journal article High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma (2019) Polifka I, Agaimy A, Herrmann E, Spath V, Trojan L, Stoeckle M, Becker F, et al. Journal article